This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. shed 3.2% to $154.54 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.4% to 6,370.17 and Dow Jones Industrial Average falling 0.3% to 44,785.50.
The stock's fall snapped an eight-day winning streak.
Charles River Laboratories International Inc. closed 32.8% below its 52-week high of $230.02, which the company reached on November 6th.
The stock underperformed when compared to some of its competitors, as Labcorp Holdings Inc. fell 0.6% to $276.56, Alnylam Pharmaceuticals Inc. rose 2.0% to $467.55, and Bio-Techne Corp. fell 0.61% to $54.00.
Trading volume totaled 394,402, compared to the 50-day average of 905,033.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 21, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.